disease-modifying treatmentmultiple sclerosisMSSpanish neuroimmunology centresAMH
…-up 6.5 years (0.01–29.4) and AMH 2.2 (0.01–17.4); 68% received disease-modifying treatment. AMH levels did not differ between patients and controls and we…
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: disease-modifying treatment ×
disease-modifying treatment
This treatment is selected. Its supporting articles are shown below.